Dr. Anne Bruinvels is a personalized medicine and digital health expert who is an experienced speaker and chairperson at international conferences and events. She does not only speak about her own activities in the patient empowerment and biomedical research fields, but is also known for her insightful talks on the future of healthcare and precision medicine.
She currently heads and is the founder of Px HealthCare, a digital health company, which develops mobile apps providing people with cancer with medical support and insight. As a data analytics venture, Px has developed a digital health platform that combines patient-engagement with data analysis. Px aims to improve the outcome of cancer treatment applying real-time patient health data.
Prior to setting up Px HealthCare, Anne was Executive Director of the European Personalized Medicine Association (EPEMED), a non-profit organization aiming to improve access to personalized medicine in Europe. Previously, Anne founded Curidium, a personalized medicine company focused on identifying companion diagnostics and therapeutics to treat patients with central nervous system disorders more effectively. She started Curidium’s business activities in 2001 and raised several rounds of angel funding before taking the company public on the AIM of the London Stock Exchange in 2006. Anne was Curidium’s CEO until late 2007 and in March 2009 Curidium was sold to a UK-based diagnostic company.
Prior, Anne was Scientific Director Business Development at Pharmagene, where she contributed to the growth of the organization from private start-up to publicly listed biotech company. She also led various research groups at SmithKline Beecham (GSK) and at Wyeth (Pfizer). Anne was awarded a PhD scholarship from Novartis and obtained her PhD from Utrecht University (the Netherlands). She was presented with the London Biotechnology Network ‘Young Entrepreneur of the Year Award’ in 2003.
Anne Bruinvels interviews Neelie Kroes and Edith Schippers on Our Future Health 2016: